Research
Hormonal
49% of patients receiving semaglutide treatment had a full stomach compared to 18% of matched controls.
Clinicians should be aware of the increased risk of full stomach in patients on semaglutide during pre-operative assessments.
StrongSupportsmedium confidence
A full stomach was observed in 21/43 (49%) of patients receiving semaglutide treatment compared with 8/44 (18%) of controls.
Why this rating
Based on a prospective, multicentre, matched case-control study design.
Source
Gastric ultrasound in patients receiving semaglutide: a prospective, multicentre, matched control study
Nils Vlaeminck et al. · Anaesthesia · 2026
cohort · n=88Cited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →